← Back to Clinical Trials
RecruitingNCT06842329

The Effect of Distraction Techniques Used in Intramuscular (IM) Injections on Pain in Adolescents Presenting to the Emergency Department With Dysmenorrhea: A Randomized Controlled Study

Trial Parameters

ConditionDysmenorrhea
SponsorDuygu MEZDE
Study TypeINTERVENTIONAL
PhaseN/A
Enrollment90
SexFEMALE
Min Age12 Years
Max Age18 Years
Start Date2024-10-01
Completion2025-04-01
Interventions
Halfer Skin Tape TechniqueShotBlocker TechniqueStandard Intramusculer injection

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Brief Summary: This study investigates the effectiveness of non-pharmacological techniques for managing dysmenorrhea (menstrual pain) in adolescents. The study focuses on methods such as Helfer Skin Tap Technique (HSTT) and ShotBlocker, which aim to reduce pain without medication. The goal is to determine how these techniques can help adolescents manage their pain more effectively. The study targets adolescents aged 12-18 who experience menstrual pain. Participants will be monitored over several months to assess the impact of these techniques on their pain levels, emotional well-being, and daily activities. Participation in the study poses minimal risks. However, the effectiveness of these pain management techniques may vary from person to person. By the end of the study, the aim is to improve pain management strategies for adolescents and gain a better understanding of the effectiveness of non-pharmacological treatments for dysmenorrhea.

Eligibility Criteria

nclusion Criteria: * Adolescents aged 12-18 years. * Experience of dysmenorrhea (menstrual pain) during at least one menstrual cycle. * Adolescents presenting to the emergency department with dysmenorrhea. * Written informed consent from participants or their legal guardians. Exclusion Criteria: * Individuals with severe cardiovascular, neurological, or other serious medical conditions. * Pregnant individuals. * Individuals undergoing regular hormonal therapy or using birth control methods. * Individuals with significant psychological or physiological conditions related to pain sensitivity (e.g., hyperalgesia). * Individuals receiving other pharmacological treatments or pain management medications during the study.

Related Trials